Precipio Inc (PRPO)

$20.55 -1.37 (-6.25%)
Market Cap 33.28M
Revenue (ttm) 18.53M
Net Income (ttm) -4.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -23.15%
Debt to Equity Ratio 0.01
Volume 20,400
Avg Vol 18,132
Day's Range N/A - N/A
Shares Out 1.62M
Stochastic %K 74%
Beta 1.18
Analysts Strong Buy
Price Target $40.00

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Hav...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 203 787 7888
Address:
4 Science Park, 3rd Floor, New Haven, United States
Awaywithshorts
Awaywithshorts Oct. 27 at 12:06 AM
$PRPO Boom
0 · Reply
houtx1
houtx1 Oct. 24 at 1:30 PM
$PRPO The 23.00 level has the most sellers waiting to unload as of now. Some sellers at 22.00 but 23 is the most important as of now. The warrant guy may have reached his breakeven and selling some at higher prices when he can. So far looks good.JMO
0 · Reply
Bader0555
Bader0555 Oct. 23 at 8:15 AM
$PRPO The last call ✈️✈️✈️
0 · Reply
Rowdyreptile
Rowdyreptile Oct. 22 at 7:49 PM
$PRPO why did they repost the same video today from 2 years ago? 😭 https://youtu.be/oCX8NpssjmU?si=BiKPygZVXcOir22-
0 · Reply
SinnagodKosher
SinnagodKosher Oct. 22 at 5:23 PM
$PRPO time to fly 😤😤😤
0 · Reply
imatisse
imatisse Oct. 22 at 8:04 AM
$PRPO $40
0 · Reply
houtx1
houtx1 Oct. 22 at 1:25 AM
$PRPO Chart! The 16.50 area was tested 3 times in the last 6 trading days and held. On Friday the volume was slightly less than today when the 16.50 area was last tested( it held and no panic sellers were found). I think the new area of support is around 18.50( area, not exact). Today had a large bullish candle , vol was about the same as today in the last 4 out of 6 trading days. I would have liked to see much higher vol with this large candle. Still a bullish sign. Sellers at 22.00 with most at 23.00 as of now. The pattern is bullish, as long as 18.50 area holds as support if the price gets there. JMO
0 · Reply
Loren77
Loren77 Oct. 21 at 8:07 PM
$PRPO come on, FOMO time
0 · Reply
Newbie3611
Newbie3611 Oct. 21 at 8:06 PM
$PRPO A new 13G was filed today by Leviticus Partners. It appears they now own 9.3% of PRPO. https://www.sec.gov/Archives/edgar/data/1043961/000101943225000027/xslSCHEDULE_13G_X01/primary_doc.xml
1 · Reply
topstockalerts
topstockalerts Oct. 21 at 5:05 PM
$PRPO setting up nicely..
0 · Reply
Latest News on PRPO
Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:03 PM EDT - 2 months ago

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Precipio Announces its Q2-2025 Financial Results

Aug 13, 2025, 5:00 PM EDT - 2 months ago

Precipio Announces its Q2-2025 Financial Results

Precipio Announces Q2-2025 Shareholder Update Call

Jul 31, 2025, 4:30 PM EDT - 3 months ago

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Jul 11, 2025, 4:30 PM EDT - 3 months ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

May 15, 2025, 6:02 PM EDT - 5 months ago

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

Precipio Announces its Q1-2025 Financial Results

May 14, 2025, 5:00 PM EDT - 5 months ago

Precipio Announces its Q1-2025 Financial Results

Precipio Announces Q1-2025 Shareholder Update Call

May 1, 2025, 5:00 PM EDT - 6 months ago

Precipio Announces Q1-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 10:50 PM EDT - 7 months ago

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Mar 17, 2025, 5:00 PM EDT - 7 months ago

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Feb 25, 2025, 9:30 AM EST - 8 months ago

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Jan 16, 2025, 5:00 PM EST - 10 months ago

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Nov 18, 2024, 6:16 PM EST - 1 year ago

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Precipio Announces Q3-2024 Shareholder Update Call

Nov 6, 2024, 5:00 PM EST - 1 year ago

Precipio Announces Q3-2024 Shareholder Update Call

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Oct 8, 2024, 10:00 AM EDT - 1 year ago

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Employee Stock Option Plan Repricing

Sep 6, 2024, 4:00 PM EDT - 1 year ago

Precipio Announces Employee Stock Option Plan Repricing

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Aug 19, 2024, 5:55 PM EDT - 1 year ago

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Precipio Announces Q2-2024 Shareholder Update Call

Aug 15, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Q2-2024 Shareholder Update Call

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:00 PM EDT - 1 year ago

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Jun 12, 2024, 4:00 PM EDT - 1 year ago

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio Secures a short-term $500K Credit Facility

May 6, 2024, 5:00 PM EDT - 1 year ago

Precipio Secures a short-term $500K Credit Facility

Precipio Announces Year end 2023 Shareholder Update Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Year end 2023 Shareholder Update Call

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Feb 13, 2024, 10:00 AM EST - 1 year ago

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Feb 6, 2024, 10:00 AM EST - 1 year ago

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Jan 23, 2024, 10:00 AM EST - 1 year ago

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Jan 17, 2024, 10:30 AM EST - 1 year ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Precipio Announces Christina Valauri joins the Board of Directors

Jan 2, 2024, 9:00 AM EST - 1 year ago

Precipio Announces Christina Valauri joins the Board of Directors

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Dec 14, 2023, 4:30 PM EST - 2 years ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Nov 20, 2023, 6:38 PM EST - 2 years ago

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Precipio Announces Q3-2023 Shareholder Update Call

Nov 16, 2023, 5:00 PM EST - 2 years ago

Precipio Announces Q3-2023 Shareholder Update Call

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Oct 18, 2023, 9:00 AM EDT - 2 years ago

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Oct 3, 2023, 10:00 AM EDT - 2 years ago

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Precipio Continues to Sign New HemeScreen™ Customers

Sep 28, 2023, 9:00 AM EDT - 2 years ago

Precipio Continues to Sign New HemeScreen™ Customers

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Sep 25, 2023, 11:00 AM EDT - 2 years ago

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Sep 21, 2023, 9:00 AM EDT - 2 years ago

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Sep 13, 2023, 9:30 AM EDT - 2 years ago

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Aug 17, 2023, 6:32 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Precipio Announces Q2-2023 Shareholder Update Call

Aug 10, 2023, 5:00 PM EDT - 2 years ago

Precipio Announces Q2-2023 Shareholder Update Call

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Aug 8, 2023, 9:00 AM EDT - 2 years ago

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Aug 3, 2023, 9:00 AM EDT - 2 years ago

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Aug 1, 2023, 9:00 AM EDT - 2 years ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Jun 14, 2023, 9:49 AM EDT - 2 years ago

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Jun 13, 2023, 9:00 AM EDT - 2 years ago

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Jun 8, 2023, 8:30 AM EDT - 2 years ago

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Jun 7, 2023, 9:30 AM EDT - 2 years ago

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

May 22, 2023, 11:00 AM EDT - 2 years ago

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

May 18, 2023, 12:34 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

Precipio Shares Growth Catalysts For HemeScreen

May 17, 2023, 4:00 PM EDT - 2 years ago

Precipio Shares Growth Catalysts For HemeScreen

Precipio Announces Q1-2023 Shareholder Update Call

May 15, 2023, 4:00 PM EDT - 2 years ago

Precipio Announces Q1-2023 Shareholder Update Call

Awaywithshorts
Awaywithshorts Oct. 27 at 12:06 AM
$PRPO Boom
0 · Reply
houtx1
houtx1 Oct. 24 at 1:30 PM
$PRPO The 23.00 level has the most sellers waiting to unload as of now. Some sellers at 22.00 but 23 is the most important as of now. The warrant guy may have reached his breakeven and selling some at higher prices when he can. So far looks good.JMO
0 · Reply
Bader0555
Bader0555 Oct. 23 at 8:15 AM
$PRPO The last call ✈️✈️✈️
0 · Reply
Rowdyreptile
Rowdyreptile Oct. 22 at 7:49 PM
$PRPO why did they repost the same video today from 2 years ago? 😭 https://youtu.be/oCX8NpssjmU?si=BiKPygZVXcOir22-
0 · Reply
SinnagodKosher
SinnagodKosher Oct. 22 at 5:23 PM
$PRPO time to fly 😤😤😤
0 · Reply
imatisse
imatisse Oct. 22 at 8:04 AM
$PRPO $40
0 · Reply
houtx1
houtx1 Oct. 22 at 1:25 AM
$PRPO Chart! The 16.50 area was tested 3 times in the last 6 trading days and held. On Friday the volume was slightly less than today when the 16.50 area was last tested( it held and no panic sellers were found). I think the new area of support is around 18.50( area, not exact). Today had a large bullish candle , vol was about the same as today in the last 4 out of 6 trading days. I would have liked to see much higher vol with this large candle. Still a bullish sign. Sellers at 22.00 with most at 23.00 as of now. The pattern is bullish, as long as 18.50 area holds as support if the price gets there. JMO
0 · Reply
Loren77
Loren77 Oct. 21 at 8:07 PM
$PRPO come on, FOMO time
0 · Reply
Newbie3611
Newbie3611 Oct. 21 at 8:06 PM
$PRPO A new 13G was filed today by Leviticus Partners. It appears they now own 9.3% of PRPO. https://www.sec.gov/Archives/edgar/data/1043961/000101943225000027/xslSCHEDULE_13G_X01/primary_doc.xml
1 · Reply
topstockalerts
topstockalerts Oct. 21 at 5:05 PM
$PRPO setting up nicely..
0 · Reply
eddiel
eddiel Oct. 21 at 4:38 PM
$PRPO lets stay above 20 forever now.
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 21 at 4:14 PM
$PRPO Current Stock Price: $19.61 No options data available.
0 · Reply
Awaywithshorts
Awaywithshorts Oct. 21 at 2:33 PM
$PRPO Earnings will be beyond awesome
0 · Reply
Rowdyreptile
Rowdyreptile Oct. 17 at 2:12 AM
$PRPO 2-3 weeks left to load before best ER in company history with new record profits & forecast. Guess they wont let us load the boat at warrant pricing but i will continue watching and adding on dips.
1 · Reply
Awaywithshorts
Awaywithshorts Oct. 16 at 11:38 PM
$PRPO Earnings in 3.5 weeks. Hoping for unaudited results early
0 · Reply
houtx1
houtx1 Oct. 16 at 12:53 PM
$PRPO interesting! Ask chatgpt! I asked chatgpt about a trend in a different stock and it gave pretty good technical analysis. Try asking it questions about stocks you have and see the results. You may have to experiment with how you ask the questions. Enter any symbol. GLTA
0 · Reply
Awaywithshorts
Awaywithshorts Oct. 15 at 9:59 PM
$PRPO Need some news ! I know it will be good but I’m impatient lol
0 · Reply
Messi0321
Messi0321 Oct. 15 at 5:51 AM
$PRPO i think the warrant guy just gave up and sold his last 10-15k shares today.
0 · Reply
houtx1
houtx1 Oct. 14 at 10:46 PM
$PRPO Chart! Something isn't right. Seems like very aggresive sell algos have taken control of the trading. Seems like they are trying to take this lower, no idea how much. Buyers today were crushed instantly. JMO lets see what happens tomorrow.
0 · Reply
kenobroker
kenobroker Oct. 14 at 5:44 PM
$PRPO stop loss grab…
0 · Reply
houtx1
houtx1 Oct. 14 at 1:00 PM
$PRPO Chart! I havent been watching this lately. The price needs to close above 20.50 for a new uptrend to begin. It's possible the uptrend that we had may have stalled. Why? Im looking at the huge volume and doji (indecision candle- no winner between bulls and bears) on 10/8. That was the highest vol since 9/8 that had a huge green bullish candle. The large volume on 10/8 should have been more bullish pushing the price higher but it didnt. It seems the warrants are still be sold or someone is exiting their position. The vol after that has been getting less and less with price dropping. The price needs to find support at 16.50 if it gets there. JMO maybe Im wrong but be alert.
0 · Reply
Rowdyreptile
Rowdyreptile Oct. 13 at 11:48 AM
$PRPO FYI - heres FDA change earlier this year that unlocked a bunch of business (much faster than even management expected)
0 · Reply